|
1.
|
Vianna HR, Soares CM, Tavares MS, Teixeira
MM and Silva AC: Inflammation in chronic kidney disease: the role
of cytokines. J Bras Nefrol. 33:351–364. 2011.(In Portuguese).
|
|
2.
|
Cheung WW, Paik KH and Mak RH:
Inflammation and cachexia in chronic kidney disease. Pediatr
Nephrol. 25:711–724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Sun YB, Qu X, Zhang X, Caruana G, Bertram
JF and Li J: Glomerular endothelial cell injury and damage precedes
that of podocytes in adriamycin-induced nephropathy. PLoS One.
8:e550272013. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Stehouwer CD: Endothelial dysfunction in
diabetic nephropathy: state of the art and potential significance
for non-diabetic renal disease. Nephrol Dial Transplant.
18:778–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Birukova AA, Birukov KG, Adyshev D, et al:
Involvement of microtubules and Rho pathway in TGF-beta1-induced
lung vascular barrier dysfunction. J Cell Physiol. 204:934–947.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Dudek SM and Garcia JG: Cytoskeletal
regulation of pulmonary vascular permeability. J Appl Physiol.
91:1487–1500. 2001.PubMed/NCBI
|
|
7.
|
Waschke J, Curry FE, Adamson RH and
Drenckhahn D: Regulation of actin dynamics is critical for
endothelial barrier functions. Am J Physiol Heart Circ Physiol.
288:H1296–H1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
You QH, Sun GY, Wang N, Chen S and Luo QL:
Role of src-suppressed C kinase substrate in rat pulmonary
microvascular endothelial hyperpermeability stimulated by
inflammatory cytokines. Inflamm Res. 59:949–958. 2010. View Article : Google Scholar
|
|
9.
|
Woolf AS, Gnudi L and Long DA: Roles of
angiopoietins in kidney development and disease. J Am Soc Nephrol.
20:239–244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Navar LG and Nishiyama A: Why are
angiotensin concentrations so high in the kidney? Curr Opin Nephrol
Hypertens. 13:107–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Yao Y, Wang L, Zhang H, et al: A novel
anticancer therapy that simultaneously targets aberrant p53 and
Notch activities in tumors. PLoS One. 7:e466272012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Akis N and Madaio MP: Isolation, culture,
and characterization of endothelial cells from mouse glomeruli.
Kidney Int. 65:2223–2227. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Rops AL, van der Vlag J, Jacobs CW, et al:
Isolation and characterization of conditionally immortalized mouse
glomerular endothelial cell lines. Kidney Int. 66:2193–2201. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Zhao JH, Huang L, Wang JP, et al: Culture
of endothelial cells from rat glomeruli and the effects of high
glucose concentration on its nitric oxide secretion. Immunol J.
23:13–15. 2007.(In Chinese).
|
|
15.
|
Green DF, Hwang KH, Ryan US and
Bourgoignie JJ: Culture of endothelial cells from baboon and human
glomeruli. Kidney Int. 41:1506–1516. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Johnston AP, Baker J, Bellamy LM, et al:
Regulation of muscle satellite cell activation and chemotaxis by
angiotensin II. PLoS One. 5:e152122010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Li Y, Wu Y, Gong X, et al: Low molecular
weight heparin decreases the permeability of glomerular endothelial
cells when exposed to pre-eclampsia serum in vitro. Nephrology
(Carlton). 17:754–759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Cooper JA, Del Vecchio PJ, Minnear FL, et
al: Measurement of albumin permeability across endothelial
monolayers in vitro. J Appl Physiol. 62:1076–1083. 1987.PubMed/NCBI
|
|
19.
|
Xu X, Jia R, Zhou Y, et al:
Microarray-based analysis: identification of hypoxia-regulated
microRNAs in retinoblastoma cells. Int J Oncol. 38:1385–1393.
2011.PubMed/NCBI
|
|
20.
|
Annuk M, Zilmer M, Lind L, Linde T and
Fellström B: Oxidative stress and endothelial function in chronic
renal failure. J Am Soc Nephrol. 12:2747–2752. 2001.PubMed/NCBI
|
|
21.
|
Garcia JG and Schaphorst KL: Regulation of
endothelial cell gap formation and paracellular permeability. J
Investig Med. 43:117–126. 1995.PubMed/NCBI
|
|
22.
|
Miura S, Saku K and Karnik SS: Molecular
analysis of the structure and function of the angiotensin II type 1
receptor. Hypertens Res. 26:937–943. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Davis B, Dei Cas A, Long DA, et al:
Podocyte-specific expression of angiopoietin-2 causes proteinuria
and apoptosis of glomerular endothelia. J Am Soc Nephrol.
18:2320–2329. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Cheng ZJ, Vapaatalo H and Mervaala E:
Angiotensin II and vascular inflammation. Med Sci Monit.
11:RA194–R205. 2005.PubMed/NCBI
|
|
25.
|
Kim J, Ahn S, Ren XR, et al: Functional
antagonism of different G protein-coupled receptor kinases for
beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl
Acad Sci USA. 102:1442–1447. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Yan M, Cheng C, Jiang J, et al: Essential
role of SRC suppressed C kinase substrates in Schwann cells
adhesion, spreading and migration. Neurochem Res. 34:1002–1010.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Suzuki Y, Ruiz-Ortega M, Lorenzo O,
Ruperez M, Esteban V and Egido J: Inflammation and angiotensin II.
Int J Biochem Cell Biol. 35:881–900. 2003. View Article : Google Scholar
|
|
28.
|
Lv J, Xu D, Perkovic V, Ma X, et al:
Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol.
23:1108–1116. 2012. View Article : Google Scholar
|
|
29.
|
Hodson EM, Willis NS and Craig J:
Corticosteroid therapy for nephrotic syndrome in children. Cochrane
Database Syst Rev. 4:CD0015332007.
|
